Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement.

Gombotz, H; Gries, M; Sipurzynski, S; Fruhwald, S; Rehak, P

Gombotz, H; Gries, M; Sipurzynski, S; Fruhwald, S; Rehak, P.

Affiliation

Gombotz H; Department of Anaesthesiology and Intensive Care Medicine, University of Graz, Austria. hans.gombotz@kfunigraz.ac.at

Acta Anaesthesiol Scand ; 44(6): 737-42, 2000 Jul.

Article in En | MEDLINE | ID: mdl-10903019

Subject(s)

Arthroplasty, Replacement, Hip; Blood Transfusion, Autologous; Erythropoietin/therapeutic use; Aged; Female; Hemodilution; Hemoglobins/metabolism; Humans; Middle Aged; Preoperative Care; Recombinant Proteins; Reticulocyte Count

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Blood Transfusion, Autologous / Erythropoietin / Arthroplasty, Replacement, Hip Type of study: Clinical_trials Limits: Aged / Female / Humans / Middle aged Language: En Journal: Acta Anaesthesiol Scand Year: 2000 Document type: Article Affiliation country: Austria

Search on Google

Add to My VHL

XML

PubMed Links